The formal methodology document explaining how Dr. Hamza Gemici's Skin longevity approach is designed, what evidence it rests on, and what limits it respects. This page is clinical transparency, not marketing.
Last reviewed: 2026-05-26
Chronological age and the skin's true biological age rarely match; the first step of the Skin longevity protocol is to build a personalised aging map of the patient's skin.
The Skin longevity approach begins by treating the patient's skin not as a single "age" number, but as a measurable, trackable biological profile. In Dr. Hamza Gemici's clinical practice this process consists of three components: multi-parameter skin analysis testing of the SkinSpan type, standardised clinical photography (Canfield/VISIA-style UV and polarised baseline), and hands-on textural and structural examination. Together, these capture far more than surface fine lines — they document estimated dermal thickness, pigmentation patterns (lentigines, melasma, erythema), pore architecture, sebum distribution, and elasticity layers.
The resulting data is translated into a personalised aging map unique to the patient. This map clarifies which regions (peri-orbital, peri-oral, malar, jawline, neck-décolleté) are driven by which mechanism, which life stage the patient is in (premenopausal, perimenopausal, postmenopausal; androgenic phase in men), and which markers will be monitored at follow-up. This record is also the foundation of the informed consent process: before planning any tretman, the physician can show the patient in concrete terms which parameter is being measured and which outcomes are realistic.
In Dr. Gemici's practice this step is never skipped, because it is not possible to later demonstrate whether something has contributed to improvement if there is no measured baseline. Findings from this assessment are compared against the same measurements taken at 3-6 month follow-ups in order to document whether the protocol is actually working.
Every patient's aging is the sum of biological mechanisms that contribute in different proportions; the second step is to name these mechanisms in order of weight.
Skin aging is not driven by a single cause. The second step of the Skin longevity protocol is to interpret the baseline data and identify which mechanisms are dominant in that specific patient. The major pathways typically reviewed include: photoaging (chronic UV-driven dermal damage and pigmentation), oxidative stress (reactive oxygen species damaging the collagen-elastin network), glycation (AGE accumulation associated with a high-glycaemic diet and insulin resistance), age-related collagen loss rate (disruption of synthesis/degradation balance), dynamic (mimetic) line pattern (frontalis, glabella, orbicularis oculi, masseter activity), and intrinsic (chronological/hormonal) aging.
Within this mapping, Dr. Gemici explicitly separates extrinsic (external: UV, smoking, air pollution, nutrition, sleep) from intrinsic (internal: genetic, hormonal, partly under epigenetic control) factors. This distinction matters: the majority of extrinsic mechanisms can be modulated by behavioural change and clinical intervention, while a portion of intrinsic mechanisms can only be slowed and not reversed. This difference is shared transparently with the patient.
The output is a mechanism prioritisation list describing where on the face, for what reason, and in what priority intervention should occur. Without such a list, tretman remains symptom-driven (e.g. botulinum to a single line); the Skin longevity approach instead builds a strategic plan that modulates the underlying mechanism.
A single procedure cannot meet the Skin longevity goal; the third step is to balance preventive, modulating and restorative layers within one coordinated plan.
The Skin longevity strategy is built on a three-layer logic. The preventive layer focuses on reducing future damage: medical-grade sun protection, topical antioxidants (vitamin C), retinoids, and age-appropriate barrier-repair cosmeceuticals. The modulating layer aims to change the pace of existing aging mechanisms; botulinum toxin to soften mimetic activity, biostimulator injections (poly-L-lactic acid, calcium hydroxyapatite), and energy-based devices (HIFU, fractional laser, radiofrequency) fall into this category. The restorative layer partially restores lost volume and structure: hyaluronic acid fileri, skinboosters, and in selected cases Profhilo (Profhilo is CE- and TİTCK-approved; it is not FDA-approved).
These three layers do not all have to be performed in one session; on the contrary, Dr. Gemici sequences them across the plan, deciding which layer enters at which visit. The tretman order is personalised to skin condition, baseline measurements, the patient's healing capacity, and social calendar. The critical point is that no single procedure is offered as "the solution" — every procedure is positioned as part of a layered whole.
This layered approach is also important for risk management. Rather than aggressive single-point interventions like high-volume filer or high-dose toxin, an evidence-informed strategic combination of smaller doses is preferred. This is the practical meaning of the "natural result" philosophy — not over-filled, immobile faces, but a profile that preserves the patient's own mimetic expression and is sustainable in the long term.
The effect of clinical procedures is proportional to the patient's daily lifestyle; the fourth step integrates sleep, nutrition, stress, and sun protection into the protocol.
Perhaps the most under-appreciated yet most outcome-defining component of the Skin longevity protocol is lifestyle integration. In Dr. Gemici's practice every patient is given a daily routine recommendation of equal weight alongside the procedure plan. This routine is built around four axes: sleep, nutrition, stress management, and sun protection.
On the sleep axis, the goal is regular nightly sleep in the 7-9 hour range; sleep is when cortisol regulation and skin repair are scheduled. On the nutrition axis, omega-3 fatty acids, polyphenols, and antioxidants from colourful fruit and vegetables are emphasised; at the same time, the contribution of high-glycaemic foods to skin aging via glycation and AGE accumulation is explained. On the stress management axis, the contribution of chronically elevated cortisol to collagen degradation is shared; a practical breathing/active-rest strategy is agreed on. On the sun protection axis, broad-spectrum SPF 50+ with intra-day re-application and physical protection (hat, sunglasses) are positioned as a daily standard.
The supplement component is also discussed. When vitamin D deficiency is confirmed serologically, dosing is given individually by the physician; collagen peptide intake is presented in light of the current literature as a supportive option — never as a replacement. "Miracle"-claim supplements and internet protocols are avoided, and every recommendation is reviewed against the patient's current tretmani and systemic conditions for potential conflict. The critical message of this step is this: even the best in-clinic tretman will not support a long-term result if the patient continues opposite habits in daily life.
Skin longevity is not a one-session project but a longitudinal programme; the fifth step is to re-assess every 3-6 months and fine-tune the protocol.
The Skin longevity approach is, by its nature, a long-horizon programme. The fifth step consists of placing the patient under clinical follow-up and fine-tuning the protocol over time. In Dr. Gemici's practice the standard follow-up interval is 3-6 months; this interval is personalised to the patient's aging rate, the applied tretman layer, and life stage (e.g. the interval may be shortened during the perimenopausal transition).
At each follow-up visit, the baseline data captured in Step 1 is re-collected: standardised photography is repeated, skin analysis tests are refreshed if needed, and the patient's subjective experience (which tretman satisfied, which fell short of expectations, which was discontinued) is recorded. This allows objective evaluation of which layer of the protocol is working and which needs to be updated in dose or technique. Longitudinal data gives the patient a concrete view of progress and gives the physician evidence for planning the next visit.
This step is also an ethical checkpoint. If the anticipated contribution to improvement is not observed, or if the patient's expectations move outside realistic limits, the plan is changed; if needed, surgical consultation (e.g. board-certified plastic surgery for advanced ptosis or blepharoplasty indication) or dermatology consultation is recommended. The "keep adding procedures to retain the client" logic is rejected. Skin longevity is a programme in which the patient is free to exit the protocol when they choose to, and in which the patient-physician relationship remains transparent throughout.
The Skin longevity 5-Step Framework is derived from the synthesis of three independent sources. First, the tretman outcomes and long-term follow-up data observed across more than 10,000 patient cases over Dr. Hamza Gemici's (Medical Doctor — Medical Aesthetic Physician) 30+ years of active clinical practice. Second, a structured review of the international longevity-medicine literature — led by evidence-based publications from academic figures shaping the field such as David Sinclair, Peter Attia, and Eric Topol, alongside RCTs and systematic reviews in peer-reviewed dermatology and aesthetic-medicine journals. Third, alignment of the framework with protocols published by international clinical centres, notably Mayo Clinic's 3-step aging strategy (prevention, modulation, restoration). The clinical validation of these three layers was carried out by Dr. Gemici through poredjenje with outcomes in his own practice; the framework iterated to its current 5-step structure as a result of that poredjenje.
The Skin longevity framework is designed in full alignment with the principles of medical advertising and patient information set out in Article 12 of the Turkish Medical Association (TTB) Code of Medical Ethics. Five foundations govern every patient interaction: (1) <strong>Informed consent</strong> — for each tretman layer, indication, alternatives, expected contribution to improvement, possible side effects, and downtime are clearly shared with the patient and written consent is obtained. (2) <strong>Realistic expectation management</strong> — the words "guarantee", the qualifier "best", specific-year claims (e.g. "10 years younger"), and exaggerated before/after rhetoric are prohibited; clinical communication is always based on measurable and documented markers. (3) <strong>Product and tretman transparency</strong> — the FDA, TİTCK, and CE approval status of every product used (e.g. Profhilo: CE- and TİTCK-approved, not FDA-approved) is clearly communicated to the patient; any off-label use is explicitly stated. (4) <strong>"Natural result" philosophy</strong> — overdosing or disproportionate volume leading to loss of mimetic expression is not targeted; a sustainable profile that preserves the patient's own facial identity is essential. (5) <strong>Conflict-of-interest declaration (COI)</strong> — any financial relationship between Dr. Gemici and the products, devices, or programmes used is openly declared; claims of "guarantee", "money-back", or "lifetime result" are never permitted under any circumstance.